R2 v. ISSI
This article was originally published in The Gray Sheet
Executive Summary
Intellectual property suit charges Intelligent Systems Software, Inc. with infringing three patents covering the ways in which R2 devices scan, process and display images. PMA-approved by FDA in 1998 for use with film-based screening mammography to assist radiologists in minimizing false readings, R2's ImageChecker received an expanded indication for diagnostic mammograms in 2001. In April, the agency approved R2 CAD technology for use with the GE Senographe full-field digital mammography system. ISSI's MammoReader was PMA-approved for "identifying areas on the original mammogram that may warrant a second review" in January, preceding film digitizer Howtek's acquisition of the firm in February (1"The Gray Sheet" Feb. 25, 2002, p. 8)...
You may also be interested in...
Howtek MammoReader Acquisition Has Value Approaching $30 Mil.
Film digitizer Howtek, Inc. is entering the mammography computer-aided detection market through the acquisition of MammoReader developer Intelligent Systems Software, Inc
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.